Сardioprotective agents with biaromatic structure. Part 1. Calcium channel blockers
Cardiovascular diseases (CVD) are widespread and the leading cause of morbidity and mortality worldwide. Drugs for the treatment of CVD have been developed since the beginning of the 20th century. To date, a large number of cardioprotective agents of various classes have been created. Nevertheless,...
Furkejuvvon:
| Váldodahkki: | |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Russo |
| Almmustuhtton: |
LLC “Publisher OKI”
2022-02-01
|
| Ráidu: | Фармакокинетика и Фармакодинамика |
| Fáttát: | |
| Liŋkkat: | https://www.pharmacokinetica.ru/jour/article/view/293 |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|